WORCESTER, Massachusetts, Sept. 25 -- The University of Massachusetts Chan Medical School issued the following news:

* * *

UMass Chan, Mass General Brigham receive green light from FDA for MLIV clinical trial

MLIV is a devasting, ultra-rare, lysosomal storage disorder characterized by delayed psychomotor development, progressive vision loss and neurological issues

By Jim Fessenden

September 24, 2026

At a glance
< . . .

Click here for more information about our products